Blog

In Vitro Toxicology Testing: The Barriers to Progression and Adoption

In Vitro Toxicology Testing: The Barriers to Progression and Adoption

Blog

The field of toxicology as a whole is at a crossroads where current and future technologies are enabling better predictions of toxicity before a substance is released for human consumption or exposure. While a few barriers remain, we are making progress towards overcoming them, from both technical and policy perspectives.

Read More

Cell-based Imaging and Screening Applications

Cell-based Imaging and Screening Applications

Blog

BioStatus develops and supplies products for cell-based imaging, cytometry and screening applications. We met with Roy Edward, Director at BioStatus during the High Content and Phenotypic Screening 2017 event to learn more.

Read More

Pharmaceutical Data Integrity: Are Your Controls Tough Enough?

Pharmaceutical Data Integrity: Are Your Controls Tough Enough?

Blog

As pharmaceutical supply chains have grown in complexity the data used by drug developers and manufacturers to make decisions is coming under greater scrutiny from regulatory authorities.

Read More

Cystic Fibrosis Treatment: New 'Amplifier' Drug Enhances Orkambi(R) Response

Amplifying Existing Treatment for Cystic Fibrosis

Blog

Researchers test new amplifier compound to treat Cystic Fibrosis and also develop better tools for drug discovery.

Read More

Liverpool Spin-Out Heading for the Top

Liverpool Spin-Out Heading for the Top

Blog

Dr Paul Colborn, CEO of University of Liverpool spin-out company, ChiroChem Ltd, talks about the growing company's big plans.

Read More

Data Integrity: A big challenge for big pharma

Data Integrity: A big challenge for big pharma

Blog

Data underpins every decision in the pharmaceutical value chain – from production line optimization, through to quality control, quality assurance and batch release.

Read More

Cell Culture: Moving from 2D to 3D and Beyond

Cell Culture: Moving from 2D to 3D and Beyond

Blog

To learn about the limitations of 2D cell culture models, the range of 3D tools available, and some of the advantages they can bring to researchers, we spoke to Dr. Richard Eglen, Vice President and General Manager of Corning Life Sciences.

Read More

Overcoming Challenges of Metabolomics

Overcoming Challenges of Metabolomics

Blog

To find out more about the recent advancements in metabolomics, we spoke to Robin Fastenau from Metabolon, a company that specialises in these areas.

Read More

Synpromics Ltd Team Up With GE Healthcare

Synpromics Ltd Team Up With GE Healthcare

Blog

Synpromics are a leading developer of synthetic promoters in the field of biosynthetics. Founder and CSO Michael Roberts gives us an overview of the company and explains the importance of their new collaboration with GE Healthcare.

Read More

A New Weapon in the War Against Antibiotic Resistance

A New Weapon in the War Against Antibiotic Resistance

Blog

We spoke to Bruce Savage, CEO at GFC Diagnostics to learn more about the MicroScreen test.

Read More